Detecting and Localizing Recurrent Prostate Cancer with Axumin® (fluciclovine F 18) injection

Detecting and Localizing Recurrent Prostate Cancer with Axumin® (Fluciclovine F 18) Injection

Sunday, October 21
12:15 PM - 1:15 PM
Location: Theater 1, Innovation Hub

Learn more about the challenges and imaging dilemmas associated with recurrent prostate cancer, and review Axumin’s clinical efficacy and safety data, along with guideline recommendations for Axumin use.

Company: Blue Earth Diagnostics Inc.
Contact: Maura Harrigan
Phone: 855-298-6461
Email: m.harrigan@blueearthdx.com


Assets

Detecting and Localizing Recurrent Prostate Cancer with Axumin® (Fluciclovine F 18) Injection



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Detecting and Localizing Recurrent Prostate Cancer with Axumin® (Fluciclovine F 18) Injection